Roche
The Evidence Solution Leader (ESL) at Roche is a strategic medical role within Product Development Medical Affairs responsible for designing and implementing global Real-World Evidence (RWE) solutions to address prioritized evidence gaps. The role provides expertise in RWE generation, insight generation, scientific engagement, and affiliate enablement to optimize evidence strategies across the product lifecycle. The ESL enhances data utility and visibility of evidence to support decision-making by internal and external stakeholders.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1896
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Roche.
Roche Breast-Cancer Drug Combination Misses Target in Study
3 days ago
Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead
1 day ago
Senior Real-World Evidence Scientist
AstraZeneca
Evidence Generation Leadership
Ferring
Evidence Generation Head
Diversity Employment
Evidence Generation Manager
Takeda Pharmaceutical Company Limited
Head of Integrated Real World Evidence Strategy Department
Pierre Fabre Group
Lead Medical Affairs Specialist, Real World Evidence & Biostatistics (Hybrid - San Diego, CA)
Insulet